The physical inability to make deeper contact with tumor surface antigens also imposes a kinetic inhibition in the ability of antigen-sensitized CD4 or CD8 cytotoxic T lymphocyte (CTL) cells to activate in response to shielded cognate antigens. The gene discussed is CD8A; the disease is neoplasm.